BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2019
View Archived Issues
Diversion is novel way of enzyme inhibition
Read More
Potassium promotes T-cell stemness
Read More
New model to trial schizophrenia preventative treatments
Read More
FDA accepts IND application for first-in-human study of PSB-205
Read More
Galapagos initiates first-in-human trial of GLPG-3121
Read More
U.S. researchers present a 5-HT2A receptor inhibitor antibody
Read More
Merck & Co. identifies new nicotinic alpha-7 receptor positive allosteric modulators
Read More
CCDC102B is strongly correlated with negative clinical outcome in breast cancer
Read More
Menin/MLL interaction inhibitors discovered at Kura Oncology
Read More
Kymera Therapeutics discovers protein cereblon inhibitors
Read More
ESSA Pharmaceuticals presents the characterization of next-generation Anitens
Read More
Leo Pharma patents phosphodiesterase PDE4D inhibitors
Read More
ABM Therapeutics presents V600E mutant raf kinase B inhibitors
Read More
Phase Ib/II data presented for DV-281 in combination with nivolumab in patients with NSCLC
Read More
New and potent IDO1 inhibitors from Merck & Co. presented
Read More
I-Mab Biopharma collaborates with Roche on clinical study of TJD-5 with Tecentriq
Read More
Alkeus begins phase III study of ALK-001 for GA secondary to AMD
Read More
Sanaria announces agreements to support development of PfSPZ vaccine for malaria
Read More
AstraZeneca DNA-PK inhibitor AZD-7648 has single-agent and combination antitumor activity
Read More
New phase I trial evaluates AVID-200 in patients with myelofibrosis
Read More
Evotec and Indivumed to use IndivuType database for colorectal cancer drug discovery
Read More
